Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Avenue
Silver Spring, MD 20993
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1997 - 2000
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1994 - 1996
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1994
- George Washington UniversityResidency, Surgery, 1989 - 1992
- Butler HospitalInternship, Transitional Year, 1988 - 1989
- The Warren Alpert Medical School of Brown UniversityClass of 1988
- Yale UniversityBA
Certifications & Licensure
- MD State Medical License 2008 - 2025
- DC State Medical License 1992 - 2020
- VA State Medical License 2017 - 2020
- TX State Medical License 2001 - 2010
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
- Clifton Howe Award for clinical excellence 1998
Clinical Trials
- Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD) Start of enrollment: 2009 Jul 01
Publications & Presentations
PubMed
- 52 citationsEnzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non–Small-Cell Lung CancerYun Oh, Roy S. Herbst, Howard Burris, Ann Cleverly, Luna Musib
Journal of Clinical Oncology. 2008-03-01 - 36 citationsRisk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients.Geetika Srivastava, Vishal Rana, Suzy Wallace, Sarah H. Taylor, Matthew Debnam
Journal of Thoracic Oncology. 2009-03-01 - 19 citationsPhase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancerWilliam N. William, Ralph Zinner, Daniel D. Karp, Y. Oh, Bonnie S. Glisson
Journal of Thoracic Oncology. 2007-08-01
Books/Book Chapters
Committees
- Chair, Glioblastoma Astrocytoma ETP's (Evidence Based Treatment Protocols) for CCE 2012 - Present
- Chair, Melanoma ETP's (Evidence Based Treatment Protocols) for CCE 2012 - Present
- Co-chair, Lung Cancer ETP's (Evidence Based Treatment Protocol) for CCE 2011 - Present
- Chair, Head & Neck Cancer ETP's (Evidence Based Treatment Protocols) for CCE 2011 - Present
- member, Clinical Quality Control Committee for CCE (Cancer Centers of Excellence) 2009 - Present
- volunteer, Minority Health Fair - Asian American Center of Frederick, under Ms. Elizabeth Chung 2009 - Present
Other Languages
- Korean, Spanish, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: